BioTech, Digital Health, Health Policy and Survey

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

BioTech

Digital Health

Health Policy

Survey

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

I’m glad to be getting back to health economic issues after spending the last couple of weeks firmly focused on consumers, digital health technologies and CES 2019. There’s a lot for me to address concerning health care costs based on news and research published over the past couple of weeks.

BioTech

BioTech Medicare Medical Billing Patient Experience

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

When this occurred, it didn’t cause more than a ripple of interest outside biotech. A 2018 national survey found that 39% of U.S. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Connected Health Pulse

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Stay Connected